Eradicating dracunculiasis: Chad and South Sudan continue to report human cases
Health on wheels: mobile clinic brings vital care to displaced Yazidis in Iraq
Notice of Concern (NOC) withdrawn for Cadila Healthcare Ltd
New measures and strong partnership having positive impact on Ebola response in the Democratic Republic of the Congo
Lymphatic filariasis: 465 million treatments delivered through expanded coverage, combined medicines
Uganda Vaccinates Front-line health-workers against Ebola
WHO strongly supports global sharing of data from TB clinical trials to maximize learning and accelerate discoveries
The General Meeting of the WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases Summary
WHO at the Union World Conference on Lung Health
Luxembourg recommits 1% of its GNI towards development
WHO HTS Info app: from concept to reality
WHO enhances Ebola Rapid Response Readiness Capacities in South Sudan
CLEAN AIR FOR HEALTH: Geneva Action Agenda
WHO Global Conference on Air Pollution and Health
Open letter to mayors on World Cities Day
Singapore wipes out measles; Australia, Brunei Darussalam and Macao SAR (China) eliminate rubella
More than 90% of the world’s children breathe toxic air every day
Consultation to guide the development of a global strategy on TB research and innovation
International exchange of viral material and expertise
WHO launches new guideline on health policy and system support to optimize community health worker programmes
The 138th session of the Executive Board opens
Strategic approach to maintain appropriate tuberculosis control activities in countries affected by the Asian tsunami disaster
Basic Psychosocial Skills: A Guide for COVID-19 Responders
Maintaining essential health services: new operational guidance for the COVID-19 context
New Ebola outbreak detected in northwest Democratic Republic of the Congo; WHO surge team supporting the response
WHO includes combination of eflornithine and nifurtimox in its Essential List of Medicines for the treatment of human African trypanosomiasis
Improving access to the best treatment for second stage T.b.gambiense
Human African Trypanosomiasis: Better treatment opportunity
Human African trypanosomiasis: number of new cases drops to historically low level in 50 years
WHO and partners acknowledge pivotal role of nurses and technicians in the control of human African trypanosomiasis
New cases of human African trypanosomiasis continue to drop
WHO meeting on elimination of human African trypanosomiasis (Trypanosoma brucei gambiense), 3–5 December 2012, Geneva
Stakeholders call on WHO to lead a network aimed at elimination of human African trypanosomiasis
Stakeholders support elimination of rhodesiense human African trypanosomiasis
Cases of sleeping sickness drop to lowest level in 75 years
Lowest caseload recorded as the world prepares to defeat sleeping sickness
Sleeping sickness: WHO scales-up data management training amid record low cases
First meeting of the Human African Trypanosomiasis Elimination Technical Advisory Group (HAT-e-TAG) Meeting Geneva, 23–25 November 2016 – Statement
Eliminating sleeping sickness as a public health problem is on track
STATEMENT -- On the recent opinion of the European Medicines Agency on fexinidazole treatment for gambiense human African trypanosomiasis
